Inventor · disambiguated record
Iva Kezic
Also filed as: KEZIC IVA
8 granted patents·8 pending applications·21 citations·filing 2021–2025
82Inventor score
Files withJANSSEN PHARMACEUTICALS INC16
Top patents by PatentIndex Score
16 records- 0196US11266627B1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·12 cites·30 claims
- 0295US11998525B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·5 cites·29 claims
- 0394US12150929B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Nov 26, 2024·2 cites·19 claims
- 0493US12161622B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·2 cites·29 claims
- 0588US12419859B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·7 claims
- 0680US12171743B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 0777US12201610B2Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·0 cites·19 claims
- 0877US2025326714A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0976US2025325515A1Forms Of AticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1075US11998524B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·0 cites·44 claims
- 1167US2025177350A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1267US2023277500A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1361US2023348377A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1459US2024238245A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1559US2025127867A1Method of treating preclinicial alzheimer's diseaseJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1659US2025228819A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →